Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
Condition(s):MorpheaLast Updated:April 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):MorpheaLast Updated:April 1, 2021Completed
Condition(s):Generalized MorpheaLast Updated:February 13, 2020Unknown status
Condition(s):MorpheaLast Updated:April 23, 2015Withdrawn
Condition(s):Symmetric Limited MorpheaLast Updated:February 18, 2019Completed
Condition(s):Morphea, Plaque FormLast Updated:September 8, 2021Withdrawn
Condition(s):Morphea; Localized SclerodermaLast Updated:September 13, 2018Terminated
Condition(s):MorpheaLast Updated:November 10, 2020Completed
Condition(s):Morphea; Scleroderma, Localized; SclerodermaLast Updated:January 23, 2024Terminated
Condition(s):Localized SclerodermaLast Updated:November 3, 2022Recruiting
Condition(s):Morphea (Circumscribed Scleroderma); Sclerotic Graft-versus-host Disease (GVHD)Last Updated:January 18, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.